About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  QUARTERLY RESULTS
Quarterly Results      
Glaxosmithkline Pharmaceuticals Ltd.
BSE Code 500660
ISIN Demat INE159A01016
Book Value 128.02
NSE Code GLAXO
Dividend Yield % 1.97
Market Cap 463918.42
P/E 49.24
EPS 55.61
Face Value 10  
Quarters :
(Rs. in Millions)
Particulars (Rs in Million) Jun 2025Mar 2025Dec 2024Sep 2024
 Audited / UnAudited UnAudited UnAudited UnAudited UnAudited
Net Sales 8048.30 9660.80 9463.60 10000.50
Total Expenditure 5540.80 6353.40 6561.80 6811.00
PBIDT (Excl OI) 2507.50 3307.40 2901.80 3189.50
Other Income 437.60 394.60 350.60 321.90
Operating Profit 2945.10 3702.00 3252.40 3511.40
Interest 4.20 5.80 0.90 2.70
Exceptional Items 0 0 0 46.90
PBDT 2940.90 3696.20 3251.50 3555.60
Depreciation 155.20 147.20 188.00 168.60
Profit Before Tax 2785.70 3549.00 3063.50 3387.00
Tax 738.70 947.60 777.70 900.10
Provisions and contingencies 0 0 0 0
Profit After Tax 2047.00 2601.40 2285.80 2486.90
Extraordinary Items 0 0 0 0
Prior Period Expenses 0 0 0 0
Other Adjustments 0.00 0.00 0.00 0.00
Net Profit 2047.00 2601.40 2285.80 2486.90
Equity Capital 1694.10 1694.10 1694.10 1694.10
Face Value (IN RS) 10 10 10 10
Reserves    
Calculated EPS 12.08 15.36 13.49 14.68
Calculated EPS (Annualised) 48.33 61.42 53.97 58.72
No of Public Share Holdings 42351510.00 42351510.00 42351510.00 42351510.00
% of Public Share Holdings 25.00 25.00 25.00 25.00
     
PBIDTM% (Excl OI) 31.16 34.24 30.66 31.89
PBIDTM% 36.59 38.32 34.37 35.11
PBDTM% 36.54 38.26 34.36 35.55
PBTM% 34.61 36.74 32.37 33.87
PATM% 25.43 26.93 24.15 24.87
 Notes Notes Notes Notes
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.